WAILEA, Hawaii — In this video from Hawaiian Eye, Jay S. Duker, MD, chief strategic scientific officer at EyePoint, discusses the development of a long-acting, sustained release, bio-erodible implant for the treatment of retinal disease.
Uncategorized
VIDEO: Duker updates progress of sustained release implant for retinal disease